## Abstract The clinical outlook for adults with acute lymphoblastic leukemia (ALL) has Improved with the use of intensive chemotherapy. Complete remissions (CR) are achieved in 80% of adults but the majority relapse on maintenance chemotherapy and a few exhibit primary resistance to induction ther
Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes
β Scribed by Antoine E. Chucrallah; Sanford A. Stass; Yang O. Huh; Maher Albitar; Hagop M. Kantarjian
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 588 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Hyperuricemia is an unusual presenting feature of acute lymphoblastic leukemia (ALL) and is generally associated with a large leukemic cell burden. We describe three children with Tβcell ALL who presented with acute renal failure and very high serum uric acid concentrations, despite a r
## Abstract ## Background Multiparameter flow cytometry is increasingly used to monitor minimal residual disease in patients with acute myeloid leukemia to identify leukemic cells by leukemiaβassociated aberrant immunophenotypes (LAIPs). Changes in LAIPs during the course of the disease may be a l
This study reports findings from a retrospective, comprehensive review of 80 cases of adult AML in regard to cytomorphology, enzyme cytochemistry (EC), flow cytometric immunophenotyping (FCI), and chromosomal analysis. From this review, we conclude that diagnostically challenging cases can only be s
Relapse in children with acute lymphoblastic leukemia (ALL) on therapy may be due to development of a resistant clone of blast cells. Seven children who presented initially with the "common"-type, L1 lymphoblast relapsed with a morphologically different and more undifferentiated blast cell. Ail were